I. Department-of-dermatology and . U976, Skin Research Institute, Hôpital Saint-Louis

T. Katsumoto, M. Whitfield, and M. Connolly, The Pathogenesis of Systemic Sclerosis, Annual Review of Pathology: Mechanisms of Disease, vol.6, issue.1, pp.509-537, 2011.
DOI : 10.1146/annurev-pathol-011110-130312

J. Baraut, L. Michel, F. Verrecchia, and D. Farge, Relationship between cytokine profiles and clinical outcomes in patients with systemic sclerosis, Autoimmunity Reviews, vol.10, issue.2, pp.65-73, 2010.
DOI : 10.1016/j.autrev.2010.08.003

M. Hasegawa, M. Fujimoto, T. Matsushita, Y. Hamaguchi, K. Takehara et al., Serum chemokine and cytokine levels as indicators of disease activity in patients with systemic sclerosis, Clinical Rheumatology, vol.158, issue.2, pp.231-237, 2011.
DOI : 10.1111/j.1365-2133.2007.08392.x

R. Giacomelli, P. Cipriani, C. Danese, F. Pizzuto, R. Lattanzio et al., Peripheral blood mononuclear cells of patients with systemic sclerosis produce increased amounts of interleukin 6, but not transforming growth factor beta 1, J Rheumatol, vol.23, pp.291-296, 1996.

L. Iversen, O. Østergaard, S. Ullman, C. Nielsen, P. Halberg et al., Circulating microparticles and plasma levels of soluble E- and P-selectins in patients with systemic sclerosis, Scandinavian Journal of Rheumatology, vol.161, issue.2, pp.473-482, 2013.
DOI : 10.1146/annurev-pathol-011110-130312

J. Distler, T. Strapatsas, D. Huscher, C. Dees, A. Akhmetshina et al., Dysbalance of angiogenic and angiostatic mediators in patients with mixed connective tissue disease, Annals of the Rheumatic Diseases, vol.70, issue.7, pp.1197-1202, 2011.
DOI : 10.1136/ard.2010.140657

R. Burt, S. Shah, K. Dill, T. Grant, M. Gheorghiade et al., Autologous non-myeloablative haemopoietic stem-cell transplantation compared with pulse cyclophosphamide once per month for systemic sclerosis (ASSIST): an open-label, randomised phase 2 trial, The Lancet, vol.378, issue.9790, pp.498-506, 2011.
DOI : 10.1016/S0140-6736(11)60982-3

J. Laar, D. Farge, J. Sont, K. Naraghi, Z. Marjanovic et al., Autologous Hematopoietic Stem Cell Transplantation vs Intravenous Pulse Cyclophosphamide in Diffuse Cutaneous Systemic Sclerosis, JAMA, vol.311, issue.24, pp.2490-2498, 2014.
DOI : 10.1001/jama.2014.6368

D. Farge, C. Henegar, M. Carmagnat, M. Daneshpouy, Z. Marjanovic et al., Analysis of immune reconstitution after autologous bone marrow transplantation in systemic sclerosis, Arthritis & Rheumatism, vol.50, issue.5, pp.1555-1563, 2005.
DOI : 10.4049/jimmunol.171.1.432

J. Baraut, E. Grigore, F. Jean-louis, S. Khelifa, C. Durand et al., Peripheral blood regulatory T cells in patients with diffuse systemic sclerosis (SSc) before and after autologous hematopoietic SCT: a pilot study, Bone Marrow Transplantation, vol.176, issue.3, pp.349-354, 2014.
DOI : 10.1016/S0140-6736(11)61100-8

H. Tsukamoto, K. Nagafuji, T. Horiuchi, H. Mitoma, H. Niiro et al., Analysis of immune reconstitution after autologous CD34+ stem/progenitor cell transplantation for systemic sclerosis: predominant reconstitution of Th1 CD4+ T cells, Rheumatology, vol.138, issue.3, pp.944-952, 2011.
DOI : 10.1111/j.1365-2249.2004.02642.x

M. Vonk, Z. Marjanovic, F. Van-den-hoogen, S. Zohar, A. Schattenberg et al., Long-term follow-up results after autologous haematopoietic stem cell transplantation for severe systemic sclerosis, Annals of the Rheumatic Diseases, vol.67, issue.1, pp.98-104, 2008.
DOI : 10.1136/ard.2007.071464

P. Gourh, F. Arnett, S. Assassi, F. Tan, M. Huang et al., Plasma cytokine profiles in systemic sclerosis: associations with autoantibody subsets and clinical manifestations, Arthritis Research & Therapy, vol.11, issue.5, p.147, 2009.
DOI : 10.1186/ar2821

M. Alecu, L. Geleriu, G. Coman, and L. G?l??escu, The interleukin-1, interleukin-2, interleukin-6 and tumour necrosis factor alpha serological levels in localised and systemic sclerosis, Rom J Intern Med, vol.36, pp.251-259, 1998.

O. Distler, J. Distler, A. Scheid, T. Acker, A. Hirth et al., Uncontrolled Expression of Vascular Endothelial Growth Factor and Its Receptors Leads to Insufficient Skin Angiogenesis in Patients With Systemic Sclerosis, Circulation Research, vol.95, issue.1, pp.109-116, 2004.
DOI : 10.1161/01.RES.0000134644.89917.96

L. Bon, A. Affandi, J. Broen, R. Christmann, R. Marijnissen et al., Proteome-wide Analysis and CXCL4 as a Biomarker in Systemic Sclerosis, New England Journal of Medicine, vol.370, issue.5, pp.433-443, 2014.
DOI : 10.1056/NEJMoa1114576